Improvement of hyperglycemia in a murine model of insulin resistance and high glucose- and inflammasome-mediated IL-1β expressions in macrophages by silymarin

Chun Ping Lu, Chien Yu Huang, Szu Hsuan Wang, Chih Hsien Chiu, Lan Hui Li, Kuo Feng Hua, Tzu Hua Wu

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Macrophages and inflammasome pathway are involved in high-glucose toxicity and development of insulin resistance. Silymarin (SMR) was known to modulate glucose homeostasis and reduce inflammation. However, it is still unknown whether SMR possess anti-hyperglycemic effects in diabetic-like knockout mice (Hnf-1αkin/−/Ins.cre mice) with insulin resistance and also unclear how SMR regulates LPS induced stress markers and pro-inflammatory cytokines under stresses of high glucose (HG) or NLRP3 inflammasome activation. Current results show that oral administration of SMR (100 mg/kg) reduced hyperglycemia in the mouse model of maturity-onset diabetes of the young type 3-like mice. In cultured macrophages, SMR (5–20 μg/ml) reduces high glucose (HG)-enhanced expressions of inducible nitric oxide synthase, nitric oxide generation stimulated by LPS; however, no effects on COX-2 expressions. The enhanced interleukin-1β (ΙL-1β) secretions in the presence of HG or palmitate were also significantly down regulated by SMR in dose-dependent manner in LPS-treated macrophages. Such observations may result from the decreased extracellular signal-regulated kinase 1/2 phosphorylation, while without affecting protein kinase C-α phosphorylation and nuclear factor-κB activation. These findings together show that SMR acts as a protector against HG-related stresses not only by lowering hyperglycemia but also suppressing HG- and inflammasome-mediated IL-1β expressions to improve insulin resistance.

Original languageEnglish
Pages (from-to)12-18
Number of pages7
JournalChemico-Biological Interactions
Volume290
DOIs
Publication statusPublished - Jun 25 2018

Fingerprint

Inflammasomes
Silymarin
Macrophages
Interleukin-1
Hyperglycemia
Insulin Resistance
Insulin
Glucose
Phosphorylation
Chemical activation
Mitogen-Activated Protein Kinase 3
Palmitates
Mitogen-Activated Protein Kinase 1
Nitric Oxide Synthase Type II
Medical problems
Knockout Mice
Protein Kinase C
Oral Administration
Toxicity
Nitric Oxide

Keywords

  • High-glucose toxicity
  • Hyperglycemia
  • Insulin resistance
  • NLRP3 inflammasome
  • Silymarin

ASJC Scopus subject areas

  • Toxicology

Cite this

Improvement of hyperglycemia in a murine model of insulin resistance and high glucose- and inflammasome-mediated IL-1β expressions in macrophages by silymarin. / Lu, Chun Ping; Huang, Chien Yu; Wang, Szu Hsuan; Chiu, Chih Hsien; Li, Lan Hui; Hua, Kuo Feng; Wu, Tzu Hua.

In: Chemico-Biological Interactions, Vol. 290, 25.06.2018, p. 12-18.

Research output: Contribution to journalArticle

@article{02ae8ac4c72248b8b028a61eefff704b,
title = "Improvement of hyperglycemia in a murine model of insulin resistance and high glucose- and inflammasome-mediated IL-1β expressions in macrophages by silymarin",
abstract = "Macrophages and inflammasome pathway are involved in high-glucose toxicity and development of insulin resistance. Silymarin (SMR) was known to modulate glucose homeostasis and reduce inflammation. However, it is still unknown whether SMR possess anti-hyperglycemic effects in diabetic-like knockout mice (Hnf-1αkin/−/Ins.cre mice) with insulin resistance and also unclear how SMR regulates LPS induced stress markers and pro-inflammatory cytokines under stresses of high glucose (HG) or NLRP3 inflammasome activation. Current results show that oral administration of SMR (100 mg/kg) reduced hyperglycemia in the mouse model of maturity-onset diabetes of the young type 3-like mice. In cultured macrophages, SMR (5–20 μg/ml) reduces high glucose (HG)-enhanced expressions of inducible nitric oxide synthase, nitric oxide generation stimulated by LPS; however, no effects on COX-2 expressions. The enhanced interleukin-1β (ΙL-1β) secretions in the presence of HG or palmitate were also significantly down regulated by SMR in dose-dependent manner in LPS-treated macrophages. Such observations may result from the decreased extracellular signal-regulated kinase 1/2 phosphorylation, while without affecting protein kinase C-α phosphorylation and nuclear factor-κB activation. These findings together show that SMR acts as a protector against HG-related stresses not only by lowering hyperglycemia but also suppressing HG- and inflammasome-mediated IL-1β expressions to improve insulin resistance.",
keywords = "High-glucose toxicity, Hyperglycemia, Insulin resistance, NLRP3 inflammasome, Silymarin",
author = "Lu, {Chun Ping} and Huang, {Chien Yu} and Wang, {Szu Hsuan} and Chiu, {Chih Hsien} and Li, {Lan Hui} and Hua, {Kuo Feng} and Wu, {Tzu Hua}",
year = "2018",
month = "6",
day = "25",
doi = "10.1016/j.cbi.2018.05.004",
language = "English",
volume = "290",
pages = "12--18",
journal = "Chemico-Biological Interactions",
issn = "0009-2797",
publisher = "Elsevier Ireland Ltd",

}

TY - JOUR

T1 - Improvement of hyperglycemia in a murine model of insulin resistance and high glucose- and inflammasome-mediated IL-1β expressions in macrophages by silymarin

AU - Lu, Chun Ping

AU - Huang, Chien Yu

AU - Wang, Szu Hsuan

AU - Chiu, Chih Hsien

AU - Li, Lan Hui

AU - Hua, Kuo Feng

AU - Wu, Tzu Hua

PY - 2018/6/25

Y1 - 2018/6/25

N2 - Macrophages and inflammasome pathway are involved in high-glucose toxicity and development of insulin resistance. Silymarin (SMR) was known to modulate glucose homeostasis and reduce inflammation. However, it is still unknown whether SMR possess anti-hyperglycemic effects in diabetic-like knockout mice (Hnf-1αkin/−/Ins.cre mice) with insulin resistance and also unclear how SMR regulates LPS induced stress markers and pro-inflammatory cytokines under stresses of high glucose (HG) or NLRP3 inflammasome activation. Current results show that oral administration of SMR (100 mg/kg) reduced hyperglycemia in the mouse model of maturity-onset diabetes of the young type 3-like mice. In cultured macrophages, SMR (5–20 μg/ml) reduces high glucose (HG)-enhanced expressions of inducible nitric oxide synthase, nitric oxide generation stimulated by LPS; however, no effects on COX-2 expressions. The enhanced interleukin-1β (ΙL-1β) secretions in the presence of HG or palmitate were also significantly down regulated by SMR in dose-dependent manner in LPS-treated macrophages. Such observations may result from the decreased extracellular signal-regulated kinase 1/2 phosphorylation, while without affecting protein kinase C-α phosphorylation and nuclear factor-κB activation. These findings together show that SMR acts as a protector against HG-related stresses not only by lowering hyperglycemia but also suppressing HG- and inflammasome-mediated IL-1β expressions to improve insulin resistance.

AB - Macrophages and inflammasome pathway are involved in high-glucose toxicity and development of insulin resistance. Silymarin (SMR) was known to modulate glucose homeostasis and reduce inflammation. However, it is still unknown whether SMR possess anti-hyperglycemic effects in diabetic-like knockout mice (Hnf-1αkin/−/Ins.cre mice) with insulin resistance and also unclear how SMR regulates LPS induced stress markers and pro-inflammatory cytokines under stresses of high glucose (HG) or NLRP3 inflammasome activation. Current results show that oral administration of SMR (100 mg/kg) reduced hyperglycemia in the mouse model of maturity-onset diabetes of the young type 3-like mice. In cultured macrophages, SMR (5–20 μg/ml) reduces high glucose (HG)-enhanced expressions of inducible nitric oxide synthase, nitric oxide generation stimulated by LPS; however, no effects on COX-2 expressions. The enhanced interleukin-1β (ΙL-1β) secretions in the presence of HG or palmitate were also significantly down regulated by SMR in dose-dependent manner in LPS-treated macrophages. Such observations may result from the decreased extracellular signal-regulated kinase 1/2 phosphorylation, while without affecting protein kinase C-α phosphorylation and nuclear factor-κB activation. These findings together show that SMR acts as a protector against HG-related stresses not only by lowering hyperglycemia but also suppressing HG- and inflammasome-mediated IL-1β expressions to improve insulin resistance.

KW - High-glucose toxicity

KW - Hyperglycemia

KW - Insulin resistance

KW - NLRP3 inflammasome

KW - Silymarin

UR - http://www.scopus.com/inward/record.url?scp=85046882243&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85046882243&partnerID=8YFLogxK

U2 - 10.1016/j.cbi.2018.05.004

DO - 10.1016/j.cbi.2018.05.004

M3 - Article

C2 - 29753610

AN - SCOPUS:85046882243

VL - 290

SP - 12

EP - 18

JO - Chemico-Biological Interactions

JF - Chemico-Biological Interactions

SN - 0009-2797

ER -